EXHIBIT 99.01

TABLE 5 - CASPI SEGMENT DETAIL OF SALES REVENUE, OPERATING EARNINGS (LOSS) AND ASSET IMPAIRMENTS AND RESTRUCTURING CHARGES

		First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Twelve Months
(Dollars in millions)		2005		2005		2005		2005		2005
Sales Revenue
Sales revenue - CASPI restructured, divested, and consolidated product lines (1)	$	--	$	--	$	--	$	--	$	--
Sales revenue - continuing product lines		319		325		333		322		1,299
Total sales revenue	$	319	$	325	$	333	$	322	$	1,299
Operating Earnings (Loss) and Asset Impairments and Restructuring Charges
Operating loss - CASPI restructured, divested, and consolidated product lines (1) (2)	$	--	$	--	$	--	$	--	$	--
Operating earnings - continuing product lines		67		64		64		34		229
Total Operating earnings (loss)	$	67	$	64	$	64	$	34	$	229
Asset impairments and restructuring charges - CASPI restructured, divested, and consolidated product lines (1)	$	1	$	1	$	1	$	1	$	4
Asset impairments and restructuring charges - continuing product lines		--		--		--		--		--
Total asset impairments and restructuring charges	$	1	$	1	$	1	$	1	$	4
Other operating income - CASPI restructured, divested, and consolidated product lines (1)	$	(2)	$	--	$	--	$	--	$	(2)
Other operating income - continuing product lines		--		--		--		--		--
Total other operating income	$	(2)	$	--	$	--	$	--	$	(2)

		First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Twelve Months
(Dollars in millions)		2004		2004		2004		2004		2004
Sales Revenue
Sales revenue - CASPI restructured, divested, and consolidated product lines (1)	$	174	$	193	$	74	$	--	$	441
Sales revenue - continuing product lines		265		283		283		282		1,113
Total sales revenue	$	439	$	476	$	357	$	282	$	1,554
Operating Earnings (Loss) and Asset Impairments and Restructuring Charges
Operating loss - CASPI restructured, divested, and consolidated product lines (1) (2)	$	(11)	$	(72)	$	(2)	$	--	$	(85)
Operating earnings - continuing product lines		41		48		40		23		152
Total Operating earnings (loss)	$	30	$	(24)	$	38	$	23	$	67
Asset impairments and restructuring charges - CASPI restructured, divested, and consolidated product lines (1)		5		66		1		--		72
Asset impairments and restructuring charges - continuing product lines		1		3		3		2		9
Total asset impairments and restructuring charges	$	6	$	69	$	4	$	2	$	81

⁽¹⁾ These businesses and product lines include acrylate ester monomers, composites (unsaturated polyester resins), inks and graphic arts raw materials, liquid resins, powder resins and textile chemicals divested on July 31, 2004 as well as other restructuring, divestiture and consolidation activities that the Company has completed related to these businesses and product lines.

⁽²⁾ Includes allocated costs consistent with the Company’s historical practices, some of which may remain and could be reallocated to the remainder of the segment and other segments.

140